by admin_63069 | Oct 9, 2024 | News You Can Use
Patients with metastatic, castration-resistant prostate cancer saw significant benefits from the combination of Xofigo and Xtandi.
by admin_63069 | Oct 7, 2024 | Related Topics
Recent article in Time magazine
by admin_63069 | Oct 2, 2024 | News You Can Use
PPP nomograms accurately stratify high- vs. low-risk groups for overall survival in early and late stages of prostate cancer and yield better prediction than established clinical risk tools.
by admin_63069 | Sep 30, 2024 | Related Topics
This report is a review of recent and emerging trends that promise to make radiation oncology for prostate cancer more efficient, effective, and patient-friendly.
by admin_63069 | Sep 25, 2024 | News You Can Use
Activation of the MYC gene in prostate cancer leads to major changes in the surrounding microenvironment.
